Effect of NRD135S.E1 in Peripheral Neuropathic Pain in Diabetic Patients
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
A multicenter, Phase 2a, randomized, double-blind, placebo (vehicle)-controlled,
parallel-group, dose-finding study designed to evaluate the efficacy, safety and tolerability
of NRD135S.E1 in adult patients with diabetes mellitus type 1 or 2 with neuropathic pain.
Potential study patients will sign informed consent prior to undergoing any study-related
procedure.